Schedule H, H1 & Narcotic Drug Register Maintenance in India: Complete Pharmacy Compliance Guide (2026)

What Are Schedule H, H1 and Narcotic Drugs?

India regulates the manufacture, sale, and distribution of medicines primarily through the Drugs and Cosmetics Act, 1940, and the Drugs Rules, 1945.

Certain controlled substances are additionally regulated under the Narcotic Drugs and Psychotropic Substances Act, 1985, and its rules.

These legal categories have different purposes and requirements.

Schedule H Medicines

Schedule H covers prescription medicines that generally cannot be sold by retail without a prescription issued by a Registered Medical Practitioner.

Licensed pharmacies must follow the applicable prescription-handling and record-keeping requirements.

Schedule H1 Medicines

Schedule H1 imposes additional controls on specified medicines, including certain antibiotics, anti-tuberculosis medicines, and other drugs subject to tighter monitoring.

For applicable retail supplies, the rules require a separate register recording specified details of the transaction.

Schedule X Medicines

Schedule X contains certain drugs requiring stricter prescription, storage, and transaction-record controls.

Schedule X is separate from Schedule H1 and must not be treated as an interchangeable classification.

Narcotic and Psychotropic Medicines

Narcotic drugs and psychotropic substances may be subject to controls under the NDPS Act and NDPS Rules.

Requirements depend on the specific substance, activity, licence, authorisation, and the type of institution handling the medicine.

Important: A medicine's inclusion in Schedule H1 or Schedule X does not automatically mean every NDPS provision applies to it. Each applicable legal classification must be checked separately.

Difference Between Schedule H, H1, Schedule X and NDPS Controls

The appropriate register depends on both the medicine and the transaction.

For example, a retail pharmacy dispensing Schedule H1 medicine to a patient follows different record procedures from a licensed pharmaceutical wholesaler supplying stock to another licensed dealer.

Schedule H Register Maintenance

Schedule H drugs are medicines subject to prescription requirements.

Under Rule 65 of the Drugs Rules, 1945, applicable prescription supplies must be documented through the prescribed register or permitted record mechanism.

Information Recorded in a Prescription Register

Depending on the transaction and applicable regulatory provisions, the records include:

• Serial number of the entry
• Date of medicine supply
• Name and address of the prescriber
• Name and address of the patient
• Name and quantity of the medicine
• Manufacturer details, batch number, and expiry date where required
• Signature of the registered pharmacist supervising the supply

The rules provide specific alternatives involving serially numbered cash or credit memo records in eligible circumstances.

A normal billing invoice should therefore not automatically be assumed to replace every prescription-register obligation.

Example: Schedule H Prescription Register

Illustrative example only. Actual records must contain all legally required particulars, including addresses and signatures where applicable.

Best Practices

Maintain a consistent process for validating prescriptions, recording dispensing details, and keeping records available for inspection.

Every transaction should be traceable to its original supporting documents.

Schedule H1 Register Maintenance: The Three-Year Record Rule

Schedule H1 was introduced to strengthen oversight of specified medicines.

Its controls are particularly important for substances associated with antimicrobial resistance and medicines requiring greater monitoring.

Legal Requirement Under Rule 65

For Schedule H1 drugs, Rule 65(3)(1)(h) provides for a separate register at the time of supply containing:

1. Name and address of the prescriber
2. Name of the patient
3. Name of the drug
4. Quantity supplied

The separate Schedule H1 register must be maintained for three years and made available for inspection.

The date of supply and a reliable transaction reference should also be captured operationally, alongside all other applicable prescription records.

Sample Schedule H1 Register

All names and transactions above are fictional. This simplified display does not replace the complete statutory register.

Examples of Schedule H1 Medicines

Examples appearing in Schedule H1 include certain formulations containing:

• Cefixime
• Ceftriaxone
• Levofloxacin
• Rifampicin
• Tramadol
• Alprazolam

The current legal classification of a product must be verified using the applicable schedule, amendment notifications, and formulation-specific provisions.

A product should not be classified solely by its brand name.

Why Is Schedule H1 Record Maintenance Important?

It helps support responsible dispensing, traceable medicine supply, and regulatory oversight.

For a busy medical store, recording the required details manually can become time-consuming, especially when handling multiple prescription transactions each day.

A properly designed digital workflow can reduce repeated data entry while retaining the information required for inspection.

However, the acceptability of a particular electronic register format should be confirmed with the relevant licensing authority.

Important Schedule H1 Regulatory Updates in 2026

Pharmaceutical businesses must keep their medicine classification databases updated as new government notifications are issued.

Pregabalin Notification — May 2026

The Ministry of Health and Family Welfare notified the inclusion of Pregabalin in Schedule H1 through G.S.R. 377(E), dated 13 May 2026.

The notification was published in the Official Gazette on 20 May 2026 and specifies commencement after 180 days.

Therefore, as of 17 October 2026, the notified amendment's commencement period had not yet elapsed.

Pharmacies and distributors should prepare their classifications, operating procedures, and record systems before the effective date.

Four Additional Drugs Proposed — August 2026

A further draft amendment, G.S.R. 745(E), dated 19 August 2026, proposes adding:

• Flupentixol
• Zopiclone
• Gabapentin
• Carisoprodol

These are proposed additions under that draft, not automatically enforceable additions merely because the draft was published.

Businesses should monitor final Gazette notifications before updating mandatory classifications.

Proposed CCTV Monitoring Requirement

In September 2026, the Union Health Ministry also announced a draft amendment proposing CCTV surveillance at medical stores as an additional safeguard related to Schedule H, H1 and X medicines.

A draft proposal should not be presented as an already effective nationwide requirement.

Practical advice: Assign responsibility for reviewing government notifications regularly and updating the medicine master only after verifying the applicable commencement date.

Schedule X Drug Register Maintenance

Schedule X medicines are subject to additional restrictions under the Drugs Rules, 1945.

For retail supply, Rule 65 provides that prescriptions must be issued in duplicate and one copy must be retained by the licensee for two years.

Other specific storage, procurement, and transaction-record requirements apply according to the licence and relevant rules.

Information a Schedule X Stock Register Should Track

A well-designed operational register may include:

• Date of purchase or sale
• Medicine name and strength
• Batch number
• Supplier information
• Purchaser details
• Quantity received
• Quantity supplied
• Opening and closing stock
• Supporting invoice or prescription reference
• Details of the authorised person handling the transaction

The statutory fields, register format, and retention requirements must be checked against the provisions applicable to the particular activity and licence.

Why Ordinary Inventory Records May Not Be Enough

A regular inventory system may show the total stock of a medicine without retaining the documentation necessary to establish whether every restricted transaction was lawful.

For controlled categories, transaction traceability and supporting documentation are just as important as the stock balance.

Narcotic Drug Register Maintenance Under the NDPS Framework

The NDPS Act, 1985, and NDPS Rules, 1985, regulate specified narcotic drugs and psychotropic substances.

The regulatory framework covers activities such as possession, sale, purchase, transport, use, and distribution, subject to applicable permissions and exemptions.

There is no single universal narcotic register format applicable to every pharmacy, wholesaler, hospital, and medical institution.

Record requirements vary according to the regulated activity and the institution's authorisation.

Special Requirements for Recognised Medical Institutions

Under the essential narcotic drugs framework, recognised medical institutions have specific record obligations.

Rule 52R includes:

• Form No. 3E: Separate patient records.
• Form No. 3H: Records of receipts and disbursements of essential narcotic drugs.
• Form No. 3-I: Annual return of procurement and disbursement.

The patient records and receipt/disbursement records must be preserved for at least two years from the date of the last entry.

The annual return is required by 31 March of the following calendar year, subject to the applicable provisions.

These forms apply to the specified recognised medical institution framework and should not be presented as universal forms for every retail chemist.

Example of a Daily Controlled-Drug Stock Reconciliation

This is a fictional arithmetic example, not a substitute for Form 3H or any other prescribed statutory record.

For a controlled drug, an unexplained difference between physical stock and recorded stock must be investigated promptly through the appropriate documented procedure.

Essential Stock Control Practices

The business should maintain transaction-level traceability and restrict access to authorised personnel.

Any damage, shortage, expiry, return, or disposal must be handled under the applicable regulatory procedure rather than through an unexplained manual inventory adjustment.

Retail Pharmacy vs Pharmaceutical Wholesale Distributor: Different Compliance Responsibilities

An important distinction is that retail dispensing and wholesale distribution are not identical legal activities.

Retail Pharmacy

A retail pharmacy supplying prescription medicines to patients must follow applicable prescription and dispensing requirements.

For Schedule H1 retail supplies, the separate register obligation is particularly important.

Pharmaceutical Wholesale Distributor

A licensed wholesaler generally supplies medicines to other authorised dealers or eligible institutions.

Rule 65 includes requirements for wholesale cash or credit memos covering details such as:

• Date of sale
• Purchaser's name and address
• Applicable purchaser licence information
• Drug name
• Quantity and batch number
• Manufacturer
• Signature of the competent person supervising the sale

The prescribed wholesale cash or credit memo records are to be preserved for three years from the date of sale.

Additional obligations may arise for controlled drugs, relevant licence conditions, and the specific transaction.

A pharmaceutical ERP should distinguish retail dispensing records from wholesale supply records rather than generating the same statutory register for every transaction.

Common Mistakes in Controlled Medicine Record Maintenance

Even established pharmacies and distributors can experience documentation problems.

Missing Prescriber Information

Entering only a doctor's name when the applicable register requires the prescriber's address creates an incomplete record.

Incorrect Drug Classification

Medicines may be assigned an outdated schedule classification after a regulatory amendment.

Missing Transaction Records

A sales invoice may update inventory while the associated prescription or controlled-drug documentation remains incomplete.

Unexplained Stock Differences

Recorded stock may not match physical stock because of unrecorded supply, returns, damage, or incorrect adjustments.

Inadequate Record Retention

Different legal categories have different retention obligations. Applying one universal retention period to every register can lead to non-compliance.

Uncontrolled Editing

Overwriting historical entries without a traceable correction process makes it difficult to reconstruct the original transaction.

Lack of Regular Review

Records created throughout the year need periodic verification, not just attention immediately before a regulatory inspection.

How Pharmacy ERP Software Can Support Register Maintenance

Modern pharmaceutical ERP software can support compliance through structured records, accurate inventory transactions, and controlled reporting.

However, the capabilities of a specific ERP must be verified before relying on it for statutory compliance.

Automatic Classification of Medicines

A medicine master can store regulatory classifications against the appropriate product or ingredient.

The classification system should support effective dates, formulation-specific rules, and multiple applicable legal controls.

Prescription Data Capture

When a qualifying medicine is supplied, the workflow can request the applicable patient and prescriber information.

Required details should be checked before the transaction is finalised.

Batch-Wise Inventory Tracking

Each purchase, sale, return, and stock correction should preserve the corresponding batch movement.

This makes it possible to trace the quantity of a medicine back to its originating transactions. See batch and expiry management and 10 batch and expiry data mistakes in pharma inventory.

Separate Register Reports

An ERP may generate distinct reports for prescription supplies, Schedule H1 records, Schedule X transactions, and relevant controlled-drug activities.

These reports must reflect the applicable statutory requirements rather than merely share a common visual template.

Transaction Audit Trails

A reliable audit trail should identify who entered, modified, approved, or reversed a transaction, and when.

Corrections should be traceable without silently destroying historical information.

Role-Based Access Control

Authorised pharmacists and responsible staff should have access only to the functions appropriate to their roles.

Sensitive patient and prescription information must be protected against unnecessary disclosure.

Secure Backup and Recovery

Digital records require secure backups and a tested restoration process.

An ERP backup is useful only if the records can be recovered accurately and made available when required.

What Should Pharmaceutical Businesses Look for in an ERP?

Before choosing pharmacy or pharmaceutical wholesale ERP software, evaluate how it handles regulated medicines in practice.

An ERP demonstration should include realistic transactions using the medicines and workflows that the business actually handles.

Maya ERP and Pharmaceutical Record Management

Maya ERP is an emerging pharmaceutical business management system developed by Maya Nexus Technologies.

Its development focuses on connecting pharmaceutical billing, batch-wise inventory, purchasing, accounting, and business reporting within an integrated platform.

For regulated medicine management, the following are important capabilities to evaluate and develop:

• Classification of medicines by applicable schedules
• Prescription information linked to invoice records
• Batch-wise purchase and sale traceability
• Separate regulatory register reporting
• Accurate stock reconciliation
• Controlled correction and cancellation procedures
• Secure handling of sensitive records

What the current Maya ERP release includes. As of October 2026, the item master lets you tag each product with a schedule category (OTC, Schedule H, Schedule H1, Schedule X, Schedule G or General), and Maya ERP provides a Schedule H1 Register report. For every Schedule H1 product sold, the report lists one row per dispensing line, in date order, with the date, bill number, patient, prescriber (doctor), drug, batch, expiry and quantity. Patient and prescriber details are captured on the invoice line. A line sold without them is still listed and marked "Not recorded" rather than dropped, and cancelled invoices are excluded.

What to verify before relying on it. The report shows the prescriber's name; it does not have a separate prescriber-address column, and it covers Schedule H1 sales only. Confirm with your licensing authority that the format meets your requirements, and do not assume that the other registers discussed in this guide (a Schedule H prescription register, Schedule X records or NDPS forms) are generated by the current release.

The capabilities listed above are important pharmaceutical compliance requirements and product-design priorities. They should not be interpreted as confirmation that every specialised statutory register is already implemented in the current Maya ERP release.

The goal of well-designed pharmacy ERP software is to make accurate record-keeping part of the daily transaction workflow, rather than an additional manual task performed afterward.

Learn more about Maya ERP at Maya Nexus Technologies.

Practical Compliance Checklist for Pharmacy Owners

Use the following checklist during internal reviews.

• Verify that the drug licence and applicable authorisations are valid.
• Check that medicine schedule classifications are current.
• Verify prescription requirements before retail supply.
• Maintain the applicable Schedule H1 separate register.
• Preserve Schedule H1 records for the required three years.
• Maintain Schedule X prescriptions and records where applicable.
• Confirm additional NDPS requirements for controlled medicines.
• Reconcile physical stock with inventory records.
• Investigate unexplained discrepancies.
• Maintain appropriate document-retention procedures.
• Restrict access to controlled-drug operations and sensitive patient data.
• Test backup and record-recovery procedures.
• Review new Gazette notifications and regulatory updates.

A documented internal review process can help identify problems before a formal inspection.

Conclusion

Schedule H, Schedule H1, Schedule X, and NDPS-related record maintenance are important responsibilities for licensed pharmaceutical businesses in India.

Although the requirements differ, they share a common objective: ensuring that regulated medicines are supplied through authorised channels with accurate, traceable documentation.

Pharmacies and distributors should treat record maintenance as an essential daily process rather than a task performed only during inspections.

When appropriately configured and legally accepted, pharmaceutical ERP software can help reduce repetitive work, improve record consistency, and support better stock control.

Accurate records, responsible dispensing, and reliable inventory management form the foundation of a well-managed pharmaceutical business.

Build Better Pharmaceutical Business Operations with Maya ERP

Explore Maya ERP for pharmaceutical billing, inventory management, and integrated accounting. See pharma wholesale workflows, inventory management or request a demo.

Website: www.mayanexustechnologies.com

Official Regulatory References

1. Central Drugs Standard Control Organisation — Drugs Rules, 1945
2. CDSCO — Gazette Notifications
3. Central Bureau of Narcotics — NDPS Rules
4. Ministry of Health and Family Welfare — Pregabalin Schedule H1 Update
5. Government of India — Draft 2026 Amendments to Schedule H1

Regulatory disclaimer

This article provides general educational information as of 17 October 2026. It does not constitute legal or professional regulatory advice. Businesses should verify current notifications, relevant state licensing requirements, and applicable NDPS authorisations before implementing compliance procedures.